Yonhap Infomax NewsDaewoong Pharmaceutical's Vice Chairman warns that South Korea's drugmakers lack funds for global R&D and cannot withstand the government's planned drug price cuts, highlighting industry-wide financial strain.
#YonhapInfomax #DaewoongPharmaceutical #DrugPriceCuts #OperatingMargin #GlobalClinicalTrials #SouthKoreaPharma #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=101995
#YonhapInfomax #DaewoongPharmaceutical #DrugPriceCuts #OperatingMargin #GlobalClinicalTrials #SouthKoreaPharma #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=101995
Daewoong Pharmaceutical Vice Chairman Yoon Jae-chun Says 'Lack of Funds Prevents Global Clinical Trials—Industry Cannot Withstand Drug Price Cuts'
Daewoong Pharmaceutical's Vice Chairman warns that South Korea's drugmakers lack funds for global R&D and cannot withstand the government's planned drug price cuts, highlighting industry-wide financial strain.